ARS Pharmaceuticals, Inc. Earnings Per Share Diluted

Quick Answer

ARS Pharmaceuticals, Inc. reported Earnings Per Share Diluted of $1.74 (loss) per share for the year ending 2025.

  • ARS Pharmaceuticals, Inc. showed a decrease of -2,275.0% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from ARS Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2021 to 2025), ARS Pharmaceuticals, Inc.'s Earnings Per Share Diluted has declined by 148.6%.
  • Historical annual values: Fiscal year 2025: $1.74 (loss) per share | Fiscal year 2024: $0.08 per share | Fiscal year 2023: $0.57 (loss) per share | Fiscal year 2022: $0.87 (loss) per share | Fiscal year 2021: $0.70 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: